Exact Sciences
EXAS
#1152
Rank
โ‚น1.730 T
Marketcap
โ‚น9,118
Share price
0.43%
Change (1 day)
80.71%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -โ‚น83.21 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚น3.08 Billion. In 2024 the company made an earning of -โ‚น90.94 Billion a decrease over its 2023 earnings that were of -โ‚น17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น83.21 Billion-8.5%
2024 -โ‚น90.94 Billion435.05%
2023 -โ‚น17 Billion-69.18%
2022 -โ‚น55.15 Billion-25.77%
2021 -โ‚น74.3 Billion1.68%
2020 -โ‚น73.07 Billion271.17%
2019 -โ‚น19.69 Billion58.99%
2018 -โ‚น12.39 Billion20.89%
2017 -โ‚น10.25 Billion-30.95%
2016 -โ‚น14.84 Billion5.09%
2015 -โ‚น14.12 Billion57.24%
2014 -โ‚น8.98 Billion116.53%
2013 -โ‚น4.15 Billion
2011 -โ‚น2.59 Billion143.73%
2010 -โ‚น1.06 Billion27.85%
2009 -โ‚น0.83 Billion0.27%
2008 -โ‚น0.83 Billion-20.95%
2007 -โ‚น1.05 Billion-13.53%
2006 -โ‚น1.21 Billion-10.07%
2005 -โ‚น1.35 Billion-21.81%
2004 -โ‚น1.72 Billion-33.44%
2003 -โ‚น2.59 Billion-6.51%
2002 -โ‚น2.77 Billion17.95%
2001 -โ‚น2.35 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Myriad Genetics
MYGN
-โ‚น37.48 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น5.89 B-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚น2.21 B-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น3.14 Billion-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น814.94 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France